1,032 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Sims Investment Management LLC

Sims Investment Management LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 1,032 shares of the healthcare conglomerate’s stock, valued at approximately $522,000. UnitedHealth Group comprises approximately 0.3% of Sims Investment Management LLC’s holdings, making the stock its 25th largest position.

Other institutional investors have also added to or reduced their stakes in the company. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $30,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group during the third quarter worth $37,000. Legacy Investment Solutions LLC bought a new position in UnitedHealth Group during the third quarter worth $57,000. DecisionPoint Financial LLC boosted its position in UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares during the period. Finally, FPC Investment Advisory Inc. boosted its position in UnitedHealth Group by 863.6% during the fourth quarter. FPC Investment Advisory Inc. now owns 106 shares of the healthcare conglomerate’s stock worth $58,000 after purchasing an additional 95 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Truist Financial reduced their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. KeyCorp reissued an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Finally, Barclays reduced their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $629.32.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $474.95 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The business has a 50 day moving average of $516.59 and a 200-day moving average of $557.16. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market capitalization of $437.09 billion, a P/E ratio of 30.64, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the business earned $5.83 EPS. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.77%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.